Literature DB >> 6154594

The in vitro effect of aprotinin upon spleen cells from normal and tumour-bearing mice exposed to PPD and tumour cells.

J G Freeman, A L Latner, G A Turner, C W Venables.   

Abstract

Aprotinin (Trasylol) is shown to enhance the response of spleen cells from normal and tumour bearing mice to PPD nd tumour cells. This enhancement is greater in the tumour-bearing mice.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6154594     DOI： 10.1007/BF01953761

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


  7 in total

1.  Effects of the antiprotease Trasylol on peripheral blood leucocytes.

Authors:  A W Thomson; R G Pugh-Humphreys; D J Tweedie; C H Horne
Journal:  Experientia       Date:  1978-04-15

2.  The effect of protease inhibitors on leucocyte migration inhibition to tuberculin extract (P.P.D.).

Authors:  A C Burden; R L Stacey; R F Wood; P R Bell
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

3.  Tumor growth inhibition mediated by trypsin inhibitor or urokinase inhibitors.

Authors:  R Verloes; G Atassi; P Dumont; L Kanarek
Journal:  Eur J Cancer       Date:  1978-01       Impact factor: 9.162

4.  Effect of aprotinin, EACA and heparin on growth and vasopeptide system of Murphy-Sturm lymphosarcoma.

Authors:  N Back; R Steger
Journal:  Eur J Pharmacol       Date:  1976-08       Impact factor: 4.432

5.  The effect of epsilon amino caproic acid and other inhibitors of proteolysis upon the response of human peripheral blood lymphocytes to phytohemagglutinin.

Authors:  R Hirschhorn; J Grossman; W Troll; G Weissmann
Journal:  J Clin Invest       Date:  1971-06       Impact factor: 14.808

6.  Inhibition of malignant cell invasion in vitro by a proteinase inhibitor.

Authors:  A L Latner; E Longstaff; K Pradhan
Journal:  Br J Cancer       Date:  1973-06       Impact factor: 7.640

7.  Anti-tumour activity of aprotinin.

Authors:  A L Latner; E Longstaff; G A Turner
Journal:  Br J Cancer       Date:  1974-07       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.